We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties. You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies. In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Zacks Market Edge Highlights: Elite Pharmaceuticals and Frequency Electronics
Read MoreHide Full Article
For Immediate Release
Chicago, IL – March 28, 2025 – Zacks Market Edge is a podcast hosted weekly by Zacks Stock Strategist Tracey Ryniec. Every week, Tracey will be joined by guests to discuss the hottest investing topics in stocks, bonds and ETFs and how it impacts your life. To listen to the podcast, click here: https://www.zacks.com/stock/news/2436479/2-defensive-american-small-cap-stocks-for-2025)
2 Defensive American Small-Cap Stocks for 2025
Welcome to Episode #439 of the Zacks Market Edge Podcast.
(1:00) - Creating A Defensive Section In Your Portfolio
(9:30) - Top Stocks To Consider Right Now
(33:00) - Episode Roundup: ELTP & FEIM
Every week, host and Zacks stock strategist, Tracey Ryniec, will be joined by guests to discuss the hottest investing topics in stocks, bonds, and ETFs and how it impacts your life.
This week, Tracey is joined by Mark Zinski, Zacks Senior Microcap Research Analyst, to discuss two defensive American small cap stocks that may provide some protection from the uncertainty in the global economy.
One company makes generic drugs and the other makes frequency control and synchronization products for the defense industry.
Elite Pharmaceuticals is a specialty pharma company developing oral, controlled-release niche generic drug products.
Headquartered in New Jersey, Elite Pharmaceuticals also operates a research and manufacturing facility in Northvale, New Jersey. It has a market cap of $500 million.
Shares of Elite Pharmaceuticals trade on the OTC market. It is a stock under $1.00. Shares of Elite Pharmaceuticals are up 216% over the last year.
It does not have a Zacks Rank at this time.
What is going on in Elite's business in 2025 that makes Mark such a fan?
Frequency Electronics designs, develops, and manufactures high-precision timing, frequency control and synchronization products for satellite and terrestrial applications such as missiles, piloted aircraft, GPS, and secure radios. Frequency Electronics has a market cap of $161.4 million. It is headquartered in New York.
On Mar 20, 2025, Frequency Electronics announced a contract increase for $12 million.
Shares of Frequency Electronics are up 48.7% over the last year. It trades on the NASDAQ.
Frequency Electronics also does not currently have a Zacks Rank.
Should Frequency Electronics be on your short list for 2025?
What Else Do You Need to Know About These 2 Defensive Small Caps Right Now?
Tune into this week's podcast to find out.
[In full disclosure, Mark owns shares of ELTP in his family portfolio. Tracey does not own shares of either stock.]
Why Haven't You Looked at Zacks' Top Stocks?
Since 2000, our top stock-picking strategies have blown away the S&P's +7.7% average gain per year. Amazingly, they soared with average gains of +48.4%, +50.2% and +56.7% per year.
Today you can access their live picks without cost or obligation.
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performancefor information about the performance numbers displayed in this press release.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Zacks Market Edge Highlights: Elite Pharmaceuticals and Frequency Electronics
For Immediate Release
Chicago, IL – March 28, 2025 – Zacks Market Edge is a podcast hosted weekly by Zacks Stock Strategist Tracey Ryniec. Every week, Tracey will be joined by guests to discuss the hottest investing topics in stocks, bonds and ETFs and how it impacts your life. To listen to the podcast, click here: https://www.zacks.com/stock/news/2436479/2-defensive-american-small-cap-stocks-for-2025)
2 Defensive American Small-Cap Stocks for 2025
Welcome to Episode #439 of the Zacks Market Edge Podcast.
Every week, host and Zacks stock strategist, Tracey Ryniec, will be joined by guests to discuss the hottest investing topics in stocks, bonds, and ETFs and how it impacts your life.
This week, Tracey is joined by Mark Zinski, Zacks Senior Microcap Research Analyst, to discuss two defensive American small cap stocks that may provide some protection from the uncertainty in the global economy.
One company makes generic drugs and the other makes frequency control and synchronization products for the defense industry.
Why should you consider small caps in 2025?
2 Defensive American Small Cap Stocks for 2025
1. Elite Pharmaceuticals, Inc. (ELTP - Free Report)
Elite Pharmaceuticals is a specialty pharma company developing oral, controlled-release niche generic drug products.
Headquartered in New Jersey, Elite Pharmaceuticals also operates a research and manufacturing facility in Northvale, New Jersey. It has a market cap of $500 million.
Shares of Elite Pharmaceuticals trade on the OTC market. It is a stock under $1.00. Shares of Elite Pharmaceuticals are up 216% over the last year.
It does not have a Zacks Rank at this time.
What is going on in Elite's business in 2025 that makes Mark such a fan?
2. Frequency Electronics, Inc. (FEIM - Free Report)
Frequency Electronics designs, develops, and manufactures high-precision timing, frequency control and synchronization products for satellite and terrestrial applications such as missiles, piloted aircraft, GPS, and secure radios. Frequency Electronics has a market cap of $161.4 million. It is headquartered in New York.
On Mar 20, 2025, Frequency Electronics announced a contract increase for $12 million.
Shares of Frequency Electronics are up 48.7% over the last year. It trades on the NASDAQ.
Frequency Electronics also does not currently have a Zacks Rank.
Should Frequency Electronics be on your short list for 2025?
What Else Do You Need to Know About These 2 Defensive Small Caps Right Now?
Tune into this week's podcast to find out.
[In full disclosure, Mark owns shares of ELTP in his family portfolio. Tracey does not own shares of either stock.]
Why Haven't You Looked at Zacks' Top Stocks?
Since 2000, our top stock-picking strategies have blown away the S&P's +7.7% average gain per year. Amazingly, they soared with average gains of +48.4%, +50.2% and +56.7% per year.
Today you can access their live picks without cost or obligation.
See Stocks Free >>
Follow us on Twitter: https://twitter.com/zacksresearch
Join us on Facebook: https://www.facebook.com/ZacksInvestmentResearch/
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
https://www.zacks.com/performance
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performancefor information about the performance numbers displayed in this press release.